Mark Strong Insider Sell
Mark Strong, an insider and also Senior VP - R&D and Quality of the leading company Heartware International Inc made trade. He sold 2,625 shares of the company with the insider trading deal valued at $137,955 USD - totalled based on $52.6 per share. Presently, he owns 2,507 shares or 0.01% of Heartware International Inc’s total market capitalization. This substantial trade occurred on 02-10-2015 and was which was filed with the U.S. SEC. The original document is ready for review here.
Heartware International Inc Sentiment and Fundamentals
It is difficult to make conclusions about Heartware International Inc’s future just from Mark Strong’s sale because in this filing, the insider also revealed option transactions. In the form, it was reported that Mark exercised options for 3,500 shares with average price 0.0000, worth . Fifteen expert analysts covering Heartware International Inc expect earnings for each share of $-2.10 2015, which would give a P/E ratio of NaN, and year on year -20.25% percent growth rate.
Heartware International Inc’s share price has decreased 22.04% in the last 200 days and it’s at the moment in smooth and strong downtrend. We don’t simply rate the stock as a -SELL- because of Mark Strong’s new stock sell. We also rate it in accordance to our trend model.
Institutional Ownership
In the previous quarter 113 institutional players holded Heartware International Inc. Octafinance tracked hedge funds have historically had a high interest in this company, and that was also the case in the last quarter. The institutional ownership was 110.89% of the stock’s outstanding shares. Its up 1.88% from Q1 2015. These professional stock owners increased the total shares they own by 354,180 to 19.18 million this quarter. There were 9 funds that closed their positions and 32 that reduced them. A total of 13 funds opened new positions in Heartware International Inc and 47 increased their holdings.
William Leland Edwards’s Palo Alto Investors Llc is the most positive hedge fund on Heartware International Inc, with ownership of 243,868 shares as of Q2 2015 for 0.79% of the fund’s portfolio. William Michaelcheck’s Mariner Investment Group Llc is another positive investment manager owning 45,000 shares of the company or 0.84% of their stocks portfolio. The stock is also 0.01% of the fund’s AUM. Further Rock Springs Capital Management Lp have 0.86% of their stock portfolio invested in the stock for 162,000 shares. Jerome Pfund And Michael Sjostrom’s Sectoral Asset Management Inc revealed it had purchased a stake worth 0.54% of the fund’s stock portfolio in Heartware International Inc. The New York-based fund Manning & Napier Advisors Llc is also an optimist about the publicly listed company, owning 653,020 shares or 0.21% of their stock portfolio.
HeartWare International NASDAQ:HTWR Company Profile
Heartware International, Inc. is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices for patients suffering from advanced heart failure. The HeartWare Ventricular Assist System (HVAD System), which includes a ventricular assist device (VAD) or blood pump, patient accessories and surgical tools, provides circulatory support for patients in the advanced stage of heart failure. The core of the HVAD System is a continuous flow blood pump, the HVAD pump. The HVAD System is designed to be implanted adjacent to the heart, avoiding abdominal surgery, directly adjacent to the heart. The Company’s hybrid system is used for suspending the impeller. The impeller is suspended within the pump housing by the opposing forces of passive magnets and hydrodynamic thrust generated by the pump impeller, which circulates a cushion of blood.
Company Website: HeartWare International
Heartware International Inc was formed in Delaware on 2008-07-29. The firm has 585 employees. Today its market cap is: $936.45 million and it has 17.67 million outstanding shares. Now there are 114.94% shareholders and the institutional ownership is 114.94%. The stock closed at $54.130001 yesterday and it had average 2 days volume of 135212 shares. It is down from the 30 days average shares volume of 149005. Heartware International Inc has a 250 days low of $50.25 and a 52w high of $95.29. The current price is below the 200 days simple moving average. Heartware International Inc last issued its quarterly earnings information on 07/30/2015. The company reported -0.47 EPS for the quarter, missing the consensus estimate of -0.46 by 0.01. The company had a revenue of 73.57 million for 6/30/2015 and 70.02 million for 3/31/2015. Therefore, the revenue was 3.55 million up.
* On December 9 - 2013 - the reporting person was granted restricted stock units to acquire 14 - 000 shares of HeartWare International common stock. The award vests in four equal installments on September 30 - 2014 - September 30 - 2015 - September 30 - 2016 and September 30 - 2017. On September 30 - 2015 (the anniversary of the reporting person’s date of hire) - 3 - 500 shares of common stock were issued to the reporting person.
* These shares were sold pursuant to a pre-arranged trading plan in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. A portion of the sale proceeds were utilized to pay taxes related to the vesting of restricted stock units and receipt of the related shares reported on this Form 4.
* The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $51.31 to $52.29. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff - upon request - information regarding the number of shares sold at each price within the range.
* The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $52.33 to $53.29. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff - upon request - information regarding the number of shares sold at each price within the range.
* The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $53.52 to $53.74. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff - upon request - information regarding the number of shares sold at each price within the range.
* Each restricted stock unit represents a contingent right to receive one share of the Company’s common stock.
